skip to content
Textbook of interventional cardiovascular pharmacology Preview this item
ClosePreview this item
Checking...

Textbook of interventional cardiovascular pharmacology

Author: Nicholas Kipshidze
Publisher: London : Informa Healthcare ; Boca Raton, FL : Distributed in North America by Taylor & Francis, 2007.
Edition/Format:   Print book : EnglishView all editions and formats
Summary:
While all interventional cardiologists have access to pharmacopeial texts and databases and are aware of the growing number of pharmacological agents in the armamentarium, questions arise as to the ideal agent or combination of agents in differing patient situations. This text offers the reader coverage of all the major pharmacological therapies used in treating the cath lab patient from the practical, personal  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Document Type: Book
All Authors / Contributors: Nicholas Kipshidze
ISBN: 9781841844381 1841844381
OCLC Number: 155673418
Description: xxxii, 646 pages : illustrations (some color) ; 30 cm
Contents: Chapter 1. An overview of hemostasis and thrombosis --
Chapter 2. Principles of antiplatelet therapy --
Chapter 3. Glycoprotein Ilb/IIIa inhibitors --
Chapter 4. Adenosine diphosphate receptor inhibitors --
Chapter 5. Phosphodiesterase inhibitors: dipyridamole and cilostazol --
Chapter 6. Heparin, low molecular weight heparin --
Chapter 7. Direct thrombin inhibition in percutaneous coronary intervention --
Chapter 8. Clinical application of direct antithrombin inhibitors in acute coronary syndrome --
Chapter 9. Oral antithrombin drugs --
Chapter 10. Rationale for direct factors Xa inhibitors in acute coronary syndromes --
Chapter 11. Combined anticoagulant and antiplatelet therapy --
Chapter 12. Fibrinolytic therapy --
Chapter 13. Resistance to antiplatelet drugs --
Chapter 14. Lipid-lowering agents --
Chapter 15. Improving the diagnosis and management of high blood pressure in the cardiac patient --
Chapter 16. Homocysteine regulators --
Chapter 17. Role of systemic antirestenotic drugs and results of current clinical trials --
Chapter 18. Role of systemic antieoplasic drugs in the treatment of restenosis after percutaneous stent implantation --
Chapter 19. Antioxidants Chapter 20. Iron chelation: deferoxamine and beyond --
Chapter 21. Stent-mediated local drug delivery --
Chapter 22. The application of controlled drug delivery principles to the development of drug-eluting stents --
Chapter 23. Brachytherapy --
Chapter 24. Polymers and drug-eluting stents --
Chapter 25. Utilization of antiproliferative and antimigratory compounds for the prevention of restenosis Chapter 26. Anti-inflammatory drugs, sirolimus, and inhibition of target of rapamycin and its effect on vascular diseases --
Chapter 27. Anti-migratory drugs and mechanisms of action --
Chapter 28. Antioangiogenetic drugs-mechanisms of action --
Chapter 29. Vasculoprotective approach for restenosis --
Chapter 30. Vascular endothelial growth factor --
Chapter 31. Gene therapy: role in myocardial protection --
Chapter 32. Antisense approach --
Chapter 33. Principles of photodynamic treatment --
Chapter 34. Angiogenesis and myogenesis --
Chapter 35. Growth factor therapy --
Chapter 36. Cell transplantation for cardiovascular repair --
Chapter 37. Clinical trials in cellular therapy --
Chapter 38. The heart failure patient --
Chapter 39. The acute coronary syndrome patient --
Chapter 40. Cardiovascular interventional pharmacology in the diabetic patient --
Chapter 41. Atrial fibrillation during cathetrization --
Chapter 42. Contrast-induced nephropathy after percutaneous coronary interventions --
Chapter 43. Erectile dysfunction --
Chapter 44. Peripheral arterial disease --
Chapter 45. Pharmacotherapy peri-percutaneous coronary intervention --
Chapter 46. Pharmacologic management of patients with CTO interventions --
Chapter 47. Newer pharmacologic approaches targeting receptors and genes --
Chapter 48. Carotid artery stenting --
Chapter 49. Anticoagulants in peripheral vascular interventions --
Chapter 50. Repairs of AAAs --
Chapter 51. Interventions for structural heart disease --
Chapter 52. Pharmacologic use of ethanol for myocardial septal ablation --
Epilogue: Anticoagulant managment of patients undergoing intervnetional procedures.
Responsibility: [edited by] Nicholas N. Kipshidze [and others] ; associate editor, Cathy Kennedy ; forewords by Valentin Fuster and Richard H. Kennedy.

Abstract:

Textbook of Interventional Cardiovascular Pharmacology  Read more...

Reviews

Editorial reviews

Publisher Synopsis

"This excellent textbook is up to date and also gives a glimpse of future pharmacologic agents and interventional techniques." New England Journal of Medicine, Vol 358 No. 7. February 2008

 
User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/155673418> # Textbook of interventional cardiovascular pharmacology
    a schema:CreativeWork, schema:Book ;
   library:oclcnum "155673418" ;
   library:placeOfPublication <http://id.loc.gov/vocabulary/countries/enk> ;
   library:placeOfPublication <http://dbpedia.org/resource/London> ; # London
   library:placeOfPublication <http://experiment.worldcat.org/entity/work/data/766884158#Place/boca_raton_fl> ; # Boca Raton, FL
   schema:about <http://experiment.worldcat.org/entity/work/data/766884158#Topic/cardiovascular_agents_therapeutic_use> ; # Cardiovascular Agents--therapeutic use
   schema:about <http://experiment.worldcat.org/entity/work/data/766884158#Topic/cardiovascular_diseases_drug_therapy> ; # Cardiovascular Diseases--drug therapy
   schema:about <http://dewey.info/class/615.71/e22/> ;
   schema:about <http://experiment.worldcat.org/entity/work/data/766884158#Topic/pharmacologie_cardiovasculaire> ; # Pharmacologie cardiovasculaire
   schema:about <http://id.worldcat.org/fast/847170> ; # Cardiovascular pharmacology
   schema:about <http://experiment.worldcat.org/entity/work/data/766884158#Topic/cardiovascular_agents_pharmacology> ; # Cardiovascular Agents--pharmacology
   schema:bookFormat bgn:PrintBook ;
   schema:contributor <http://viaf.org/viaf/43065612> ; # Nicholas Kipshidze
   schema:datePublished "2007" ;
   schema:description "Chapter 1. An overview of hemostasis and thrombosis -- Chapter 2. Principles of antiplatelet therapy -- Chapter 3. Glycoprotein Ilb/IIIa inhibitors -- Chapter 4. Adenosine diphosphate receptor inhibitors -- Chapter 5. Phosphodiesterase inhibitors: dipyridamole and cilostazol -- Chapter 6. Heparin, low molecular weight heparin -- Chapter 7. Direct thrombin inhibition in percutaneous coronary intervention -- Chapter 8. Clinical application of direct antithrombin inhibitors in acute coronary syndrome -- Chapter 9. Oral antithrombin drugs -- Chapter 10. Rationale for direct factors Xa inhibitors in acute coronary syndromes -- Chapter 11. Combined anticoagulant and antiplatelet therapy -- Chapter 12. Fibrinolytic therapy -- Chapter 13. Resistance to antiplatelet drugs -- Chapter 14. Lipid-lowering agents -- Chapter 15. Improving the diagnosis and management of high blood pressure in the cardiac patient -- Chapter 16. Homocysteine regulators -- Chapter 17. Role of systemic antirestenotic drugs and results of current clinical trials -- Chapter 18. Role of systemic antieoplasic drugs in the treatment of restenosis after percutaneous stent implantation -- Chapter 19. Antioxidants Chapter 20. Iron chelation: deferoxamine and beyond -- Chapter 21. Stent-mediated local drug delivery -- Chapter 22. The application of controlled drug delivery principles to the development of drug-eluting stents -- Chapter 23. Brachytherapy -- Chapter 24. Polymers and drug-eluting stents -- Chapter 25. Utilization of antiproliferative and antimigratory compounds for the prevention of restenosis"@en ;
   schema:description "While all interventional cardiologists have access to pharmacopeial texts and databases and are aware of the growing number of pharmacological agents in the armamentarium, questions arise as to the ideal agent or combination of agents in differing patient situations. This text offers the reader coverage of all the major pharmacological therapies used in treating the cath lab patient from the practical, personal perspective of those actively involved in interventional cardiology."@en ;
   schema:exampleOfWork <http://worldcat.org/entity/work/id/766884158> ;
   schema:inLanguage "en" ;
   schema:name "Textbook of interventional cardiovascular pharmacology"@en ;
   schema:productID "155673418" ;
   schema:publication <http://www.worldcat.org/title/-/oclc/155673418#PublicationEvent/london_informa_healthcare_boca_raton_fl_distributed_in_north_america_by_taylor_&_francis_2007> ;
   schema:publisher <http://experiment.worldcat.org/entity/work/data/766884158#Agent/distributed_in_north_america_by_taylor_&_francis> ; # Distributed in North America by Taylor & Francis
   schema:publisher <http://experiment.worldcat.org/entity/work/data/766884158#Agent/informa_healthcare> ; # Informa Healthcare
   schema:workExample <http://worldcat.org/isbn/9781841844381> ;
   umbel:isLike <http://bnb.data.bl.uk/id/resource/GBA752349> ;
   wdrs:describedby <http://www.worldcat.org/title/-/oclc/155673418> ;
    .


Related Entities

<http://dbpedia.org/resource/London> # London
    a schema:Place ;
   schema:name "London" ;
    .

<http://experiment.worldcat.org/entity/work/data/766884158#Agent/distributed_in_north_america_by_taylor_&_francis> # Distributed in North America by Taylor & Francis
    a bgn:Agent ;
   schema:name "Distributed in North America by Taylor & Francis" ;
    .

<http://experiment.worldcat.org/entity/work/data/766884158#Agent/informa_healthcare> # Informa Healthcare
    a bgn:Agent ;
   schema:name "Informa Healthcare" ;
    .

<http://experiment.worldcat.org/entity/work/data/766884158#Topic/cardiovascular_agents_pharmacology> # Cardiovascular Agents--pharmacology
    a schema:Intangible ;
   schema:name "Cardiovascular Agents--pharmacology"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/766884158#Topic/cardiovascular_agents_therapeutic_use> # Cardiovascular Agents--therapeutic use
    a schema:Intangible ;
   schema:name "Cardiovascular Agents--therapeutic use"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/766884158#Topic/cardiovascular_diseases_drug_therapy> # Cardiovascular Diseases--drug therapy
    a schema:Intangible ;
   schema:name "Cardiovascular Diseases--drug therapy"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/766884158#Topic/pharmacologie_cardiovasculaire> # Pharmacologie cardiovasculaire
    a schema:Intangible ;
   schema:name "Pharmacologie cardiovasculaire"@fr ;
    .

<http://id.worldcat.org/fast/847170> # Cardiovascular pharmacology
    a schema:Intangible ;
   schema:name "Cardiovascular pharmacology"@en ;
    .

<http://viaf.org/viaf/43065612> # Nicholas Kipshidze
    a schema:Person ;
   schema:familyName "Kipshidze" ;
   schema:givenName "Nicholas" ;
   schema:name "Nicholas Kipshidze" ;
    .

<http://worldcat.org/isbn/9781841844381>
    a schema:ProductModel ;
   schema:isbn "1841844381" ;
   schema:isbn "9781841844381" ;
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.